Course Director

Matt Kalaycio
Matt Kalaycio, MD, FACP

Chairman, Department of Hematology and Medical Oncology
Staff, Transplantation Center and Department of Cancer Biology
Taussig Cancer Center
Cleveland Clinic
Professor, Cleveland Clinic Lerner College of Medicine
Case Western Reserve University
Cleveland, OH


Jae Park, MD

Memorial Sloan Kettering Cancer Center
New York, NY

Accredited by

Cleveland Clinic Center for Continuing Education

View Activity Materials

Course Description

Learning Objectives
1. Review basic CAR design and CD19 CAR experience
2. Describe AML CAR target identification challenges
3. Identify BiTE and DART therapeutic approaches in AML
4. Highlight AML CAR clinical experience to date and future AML CAR (ASH 2018 and beyond)
5. Critically appraise results of research on the evolving role of chimeric antigen receptor-T cell (CAR-T) therapy in myeloid malignancies

Activity Details

Credit Types:CME
Credit Amount:0.50 Credits
Release Date:2019-Jan-17
Expiration Date:2021-Jan-17
Estimated Time for Completion:30 minutes
Registration Required:No

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.